Latest Financial Health News

Page 68 of 86
Experience Co Limited has announced a significant on-market share buy-back of up to 10% of its issued capital, signaling renewed confidence in its financial health and future prospects.
Victor Sage
Victor Sage
26 May 2025
Viva Leisure has taken a strategic 33% stake in Gorilla X Labs, aiming to deepen its footprint in the sports nutrition market and enhance member offerings across its platforms.
Victor Sage
Victor Sage
26 May 2025
Noble Helium has secured significant cost savings by negotiating the removal of the Marriott rig from Tanzania at no economic risk, while preparing a leaner drilling approach with the BorExpert rig.
Maxwell Dee
Maxwell Dee
26 May 2025
3P Learning forecasts steady revenue for FY25 but anticipates a significant 20% uplift in underlying EBITDA and a stronger net cash position, driven by strategic product expansions.
Victor Sage
Victor Sage
23 May 2025
Lucapa Diamond Company and its subsidiaries have appointed voluntary administrators as they embark on a dual-track recapitalisation and sale process to address financial distress.
Maxwell Dee
Maxwell Dee
23 May 2025
Bendigo and Adelaide Bank reported a slight dip in its Common Equity Tier 1 ratio to 10.83% for the March 2025 quarter, reflecting dividend payments and increased residential lending. Despite this, the bank sustained robust liquidity and funding metrics well above regulatory minimums.
Victor Sage
Victor Sage
23 May 2025
SKS Technologies has delivered a robust first half in 2025, showcasing strong revenue growth and a burgeoning project pipeline, underpinned by zero debt and strategic expansion in data centres and traditional electrical services.
Sophie Babbage
Sophie Babbage
22 May 2025
RPM Automotive Group has launched a fully operational tyre recycling plant, boosting its earnings potential while reporting steady revenue and improved profitability for the nine months FYTD.
Victor Sage
Victor Sage
22 May 2025
AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.
Ada Torres
Ada Torres
22 May 2025
Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.
Ada Torres
Ada Torres
21 May 2025
Catapult Group International Ltd reported a 16.5% increase in revenue to $116.5 million for FY25, driven by strong subscription growth and improved operational efficiency. The company narrowed its net loss after tax to $8.8 million, signaling progress in its global sports technology strategy.
Sophie Babbage
Sophie Babbage
21 May 2025
James Hardie has released its financial results for the fourth quarter and full year ended March 31, 2025, accompanied by a suite of detailed reports filed with both the ASX and SEC.
Victor Sage
Victor Sage
21 May 2025